BioGaia AB (publ) BIOG-B.ST Stock
BioGaia AB (publ) Price Chart
BioGaia AB (publ) BIOG-B.ST Financial and Trading Overview
| BioGaia AB (publ) stock price | 115.9 SEK |
| Previous Close | 112.5 SEK |
| Open | 112.4 SEK |
| Bid | 111.9 SEK x 0 |
| Ask | 112.1 SEK x 0 |
| Day's Range | 110.8 - 112.4 SEK |
| 52 Week Range | 68.88 - 114.9 SEK |
| Volume | 9.71K SEK |
| Avg. Volume | 107.58K SEK |
| Market Cap | 11.18B SEK |
| Beta (5Y Monthly) | 0.693103 |
| PE Ratio (TTM) | 5.8608055 |
| EPS (TTM) | 3.62 SEK |
| Forward Dividend & Yield | 1.45 (1.33%) |
| Ex-Dividend Date | May 8, 2023 |
| 1y Target Est | 122.5 SEK |
BIOG-B.ST Valuation Measures
| Enterprise Value | 9.54B SEK |
| Trailing P/E | 5.8608055 |
| Forward P/E | 31.37255 |
| PEG Ratio (5 yr expected) | 2.12 |
| Price/Sales (ttm) | 9.424486 |
| Price/Book (mrq) | 5.4195294 |
| Enterprise Value/Revenue | 8.042 |
| Enterprise Value/EBITDA | 23.839 |
Trading Information
BioGaia AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.693103 |
| 52-Week Change | 19.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 114.9 SEK |
| 52 Week Low | 68.88 SEK |
| 50-Day Moving Average | 100.37 SEK |
| 200-Day Moving Average | 91.51 SEK |
BIOG-B.ST Share Statistics
| Avg. Volume (3 month) | 107.58K SEK |
| Avg. Daily Volume (10-Days) | 105.09K SEK |
| Shares Outstanding | 97.28M |
| Float | 80.84M |
| Short Ratio | N/A |
| % Held by Insiders | 3.59% |
| % Held by Institutions | 52.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.45 |
| Trailing Annual Dividend Yield | 1.28% |
| 5 Year Average Dividend Yield | 108.00% |
| Payout Ratio | 0.038399998 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 34.86% |
| Operating Margin (ttm) | 32.47% |
| Gross Margin | 72.70% |
| EBITDA Margin | 33.73% |
Management Effectiveness
| Return on Assets (ttm) | 10.56% |
| Return on Equity (ttm) | 20.44% |
Income Statement
| Revenue (ttm) | 1.19B SEK |
| Revenue Per Share (ttm) | 11.74 SEK |
| Quarterly Revenue Growth (yoy) | 28.89% |
| Gross Profit (ttm) | 801.93M SEK |
| EBITDA | 400.07M SEK |
| Net Income Avi to Common (ttm) | 413.42M SEK |
| Diluted EPS (ttm) | 19.11 |
| Quarterly Earnings Growth (yoy) | 52.00% |
Balance Sheet
| Total Cash (mrq) | 1.58B SEK |
| Total Cash Per Share (mrq) | 15.65 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.321 |
| Book Value Per Share (mrq) | 20.666 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 324.31M SEK |
| Levered Free Cash Flow (ttm) | 217.33M SEK |
Profile of BioGaia AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Kungsbroplan 3 |
| ZIP | 112 27 |
| Phone | 46 8 55 52 93 00 |
| Website | https://www.biogaia.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 211 |
BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylorithe gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Q&A For BioGaia AB (publ) Stock
What is a current BIOG-B.ST stock price?
BioGaia AB (publ) BIOG-B.ST stock price today per share is 115.9 SEK.
How to purchase BioGaia AB (publ) stock?
You can buy BIOG-B.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioGaia AB (publ)?
The stock symbol or ticker of BioGaia AB (publ) is BIOG-B.ST.
Which industry does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does BioGaia AB (publ) have in circulation?
The max supply of BioGaia AB (publ) shares is 100.98M.
What is BioGaia AB (publ) Price to Earnings Ratio (PE Ratio)?
BioGaia AB (publ) PE Ratio is 32.01657500 now.
What was BioGaia AB (publ) earnings per share over the trailing 12 months (TTM)?
BioGaia AB (publ) EPS is 3.62 SEK over the trailing 12 months.
Which sector does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) sector is Healthcare.
BioGaia AB (publ) BIOG-B.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 439.38 DKK 64.42 USD |
-0.4
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Mid_Cap_GI OMXSMCGI | 796.9 SEK 77.79 USD |
-0.02
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX Stockholm Benchmark_GI Exp OMXSBGIEXP | 1890.96 SEK 184.58 USD |
+0.74
|
— — | — — | — — | — - | — — |
| OMX Stockholm Benchmark Cap_PI OMXSBCAPPI | 917.81 SEK 89.59 USD |
+0.07
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 548.69 SEK 53.56 USD |
+0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 439.19 EUR 480.1 USD |
-0.42
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}